Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Cancer' Category

NCCN Evidence Blocks

NCCN recently released a new approach to measure the value of cancer medicines. The approach–known as Evidence Blocks–evaluates medications on 5 dimensions: Efficacy of regimens, Safety of regimens, Quality and quantity of evidence for regimens, Consistency of evidence for regimens, and Affordability of regimens. Each criteria is ranked on a 1 to 5 block scale. […]

Read the rest of this entry »

What is the cancer incidence rate in your state?

Find out at the CDC’s website. They have incidence information by cancer type and gender for all states between 1999 and 2012. Below is a sample chart you can produce with these data.

Read the rest of this entry »

ASCO Poster

Tomorrow I will be presenting a poster on “How well do surrogate endpoints and overall survival endpoints in clinical trials predict real-world survival?”at the American Society of Clinical Oncology (ASCO) conference.  Below is the poster information if anyone wants to stop by.  You can download the poster HERE. Session Title: Poster Session: Health Services Research and Quality […]

Read the rest of this entry »

Quality-Adjusted Cost Of Care

One of my paper (along with co-authors Darius Lakdawalla, Claudio Lucarelli, Sean Nicholson, Zeba M. Khan and Tomas J. Philipson) was published at Health Affairs.  The title of the study is: Quality-Adjusted Cost Of Care: A Meaningful Way To Measure Growth In Innovation Cost Versus The Value Of Health Gains.  The abstract is below. Technology drives both […]

Read the rest of this entry »

A Neurosurgeon and A Patient

The moving story of Paul Kalanithi. That message is simple: When you come to one of the many moments in life when you must give an account of yourself, provide a ledger of what you have been, and done, and meant to the world, do not, I pray, discount that you filled a dying man’s […]

Read the rest of this entry »

What is Precision Medicine?

In his State of the Union, the President said that he was looking for additional funds for precision medicine. What would these funds be used for and how much money are we talking about? The details were revealed last week. The Presdient describes precision medicine as “delivering the right treatments, at the right time, every […]

Read the rest of this entry »

Cancer Care Myths

Below are excerpts from a recent Health Affairs paper by Goldman and Philipson (2014): Myth #1: The War on Cancer has been a failure.  Survival rates for all cancers increased by almost four years during the period 1988–2000. Myth 2: Detection, Not Treatment, Accounts For Most Of The Survival Gains.  During 1988–2000 almost 80 percent of […]

Read the rest of this entry »

Trends in Cancer Care Near the End of Life

The Dartmouth Atlas released a new report describing how end-of-life cancer care is changing over time. Their analysis uses data from a 20 percent sample of all Medicare beneficiaries who died between the ages of 66 and 99 years during 2010, who had cancer diagnosis with a poor prognosis. The authors find that: Deaths in […]

Read the rest of this entry »

Thoughts on IOM’s ‘Delivering High-Quality Cancer Care’ Report

The Institute of Medicine (IOM) makes a number of recommendations on how to improve cancer care in their 2013 report.  I have listed them all here.  For some of these recommendations, I have comments below. The Centers for Medicare & Medicaid Services and other payers should design, implement, and evaluate innovative payment models that incentivize […]

Read the rest of this entry »

Access to Oncology Care

Oftentimes, health services research measure access as the distance between a patient and the nearest provider of a given type (e.g., hospital, physician).  This issue of access is particularly relevant for individuals with cancer, since cancer care typically requires supervisions from specialist oncologists.  In most cases, health services researchers assume that individuals located far from […]

Read the rest of this entry »